PDCD1 and glioblastoma: Interestingly, while patients with high RCD.GP scores showed improved OS and enhanced immunotherapy response in various cancer types like UC, NSCLC and SKCM, a different trend was observed in GBM patients treated with anti-PD-1 therapy.